While various approaches are being explored to identify biomarkers for new PSA reflex tests [19], proteomics is an especially attractive approach for this indication given that methylated DNA signatures in blood, though highly predictive for other cancers, show relatively low sensitivity for the detection of prostate cancer [20]. The gene discussed is KLK3; the disease is prostate carcinoma.